4.2 Review

Bortezomib-induced Epstein-Barr virus and Kaposi sarcoma herpesvirus lytic gene expression: oncolytic strategies

Related references

Note: Only part of the references are listed.
Article Hematology

Bortezomib-Induced Tumor Lysis Syndrome in a Patient With HIV-Negative Plasmablastic Lymphoma

Mark Lipstein et al.

Clinical Lymphoma Myeloma & Leukemia (2010)

Article Multidisciplinary Sciences

Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma

Kristopher A. Sarosiek et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Infectious Diseases

Update on HHV-8-Associated Malignancies

Meena Sunil et al.

Current Infectious Disease Reports (2010)

Review Hematology

HIV-associated lymphomas and gamma-herpesviruses

Antonino Carbone et al.

BLOOD (2009)

Article Immunology

Molecular and Clinical Assessment in the Treatment of AIDS Kaposi Sarcoma with Valproic Acid

Maryjo Lechowicz et al.

CLINICAL INFECTIOUS DISEASES (2009)

Letter Hematology

AIDS-related plasmablastic lymphoma with dramatic, early response to bortezomib

Prithviraj Bose et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2009)

Letter Hematology

Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphoma

Emmanuelle Boulanger et al.

BRITISH JOURNAL OF HAEMATOLOGY (2008)

Article Biochemistry & Molecular Biology

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors

De-Xue Fu et al.

NATURE MEDICINE (2008)

Article Oncology

Virus-associated tumor imaging by induction of viral gene expression

De-Xue Fu et al.

CLINICAL CANCER RESEARCH (2007)

Review Oncology

Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy

Mario Boccadoro et al.

CANCER CELL INTERNATIONAL (2005)

Article Virology

NF-κB inhibits gammaherpesvirus lytic replication

HJ Brown et al.

JOURNAL OF VIROLOGY (2003)